Prevention Latest News Archive

FDA: MS Drug Linked To Cases of Cervicocephalic Arterial Dissection

FDA: MS Drug Linked To Cases of Cervicocephalic Arterial Dissection

The FDA has issued a warning regarding rare cases of ischemic and hemorrhagic stroke and cervicocephalic arterial dissection in patients with MS shortly after receiving Lemtrada.

Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk

Noninferior CV Outcomes for Linagliptin in T2D With High CV, Renal Risk

Linagliptin added to usual care compared with placebo added to usual care resulted in a noninferior risk for a composite cardiovascular or renal outcome over a median 2.2 years.

HbA1c Variability in General Population Increases Risk for Cardiovascular Events, All-Cause Mortality

HbA1c Variability in General Population Increases Risk for Cardiovascular Events, All-Cause Mortality

People who do not have diabetes or cardiovascular disease but have high hemoglobin A1c variability tend to be at greater risk for major adverse cardiovascular events and all-cause mortality.

Splanchnic Vein Thrombosis May Increase Risk for Arterial Cardiovascular Events

Splanchnic Vein Thrombosis May Increase Risk for Arterial Cardiovascular Events

Patients with splanchnic vein thrombosis may be at an increased risk for bleeding and arterial cardiovascular events for years after diagnosis.

CVD May Be Associated With Neuronal Loss in Treated HIV+ Patients

CVD May Be Associated With Neuronal Loss in Treated HIV+ Patients

PLWHIV who have received treatment had lower whole-brain standardized uptake values compared to healthy controls with risk for CVD as the best predictor.

Updated Physical Activity Guidelines Released at AHA Scientific Sessions 2018

Updated Physical Activity Guidelines Released at AHA Scientific Sessions 2018

This guidance, updated for the first time since 2008, provides evidence-based recommendations for children (ages 3-17) and adults.

Pregnancy Loss Associated With Greater Long-Term CVD Risk

Pregnancy Loss Associated With Greater Long-Term CVD Risk

Pregnancy loss was associated with a greater long-term risk for incident cardiovascular events.

Patterns of Cardiometabolic Health During Menopause Transition

Patterns of Cardiometabolic Health During Menopause Transition

Women entering menopause had patterns of cardiometabolic risk components related to race/ethnicity.

How Employer-Sponsored Wellness Programs Create Ethical Dilemma for Physicians

How Employer-Sponsored Wellness Programs Create Ethical Dilemma for Physicians

Employer-sponsored wellness programs can put physicians in an unenviable position.

Poor Performance of CV Risk Calculators in Rheumatoid Arthritis

Poor Performance of CV Risk Calculators in Rheumatoid Arthritis

Investigators examined the predictive accuracy of ERS-RA and compared it with a risk calculator without RA-specific risk factors in patients with new-onset RA.

Dose-Dependent Relationship Between Smoking and Cardiovascular Complications in T1D

Dose-Dependent Relationship Between Smoking and Cardiovascular Complications in T1D

There is a dose-dependent association between smoking and coronary heart disease in patients with type 1 diabetes.

CVD Risk Reduced in Rheumatoid Arthritis Treated With Methotrexate and bDMARDs

CVD Risk Reduced in Rheumatoid Arthritis Treated With Methotrexate and bDMARDs

A reduction in CVD risk was found with concomitant methotrexate and bDMARD use for rheumatoid arthritis.

Severity of Metabolic Syndrome Indicates Risk for CVD in Prediabetes

Severity of Metabolic Syndrome Indicates Risk for CVD in Prediabetes

Researchers analyzed how improvements in metabolic syndrome may impact the risk of developing type 2 diabetes and cardiovascular disease in patients with prediabetes.

Variations in Influenza Vaccination Coverage Among Healthcare Employees Reported

Variations in Influenza Vaccination Coverage Among Healthcare Employees Reported

Wide variations in influenza vaccine coverage have been noted across healthcare personnel based on occupation and worksite.

Cardiovascular Risks Associated With Diclofenac Initiation

Cardiovascular Risks Associated With Diclofenac Initiation

Patients initiating diclofenac may have an increased risk for cardiovascular events compared with individuals using paracetamol, other traditional nonsteroidal anti-inflammatory drugs (NSAIDs), or those not taking NSAIDs.

Abacavir Linked to Increased CVD Risk Among Individuals With HIV

Abacavir Linked to Increased CVD Risk Among Individuals With HIV

Exposure to abacavir is associated with an increased risk for cardiovascular disease in individuals infected with HIV.

Central Obesity Not Predictive of Cardiovascular Events in Older Men

Central Obesity Not Predictive of Cardiovascular Events in Older Men

Central obesity might not be an effective predictor for atherosclerotic cardiovascular disease events in older men.

FDA Publishes Final Guidance on Heparin-Containing Devices

FDA Publishes Final Guidance on Heparin-Containing Devices

The intent of the document is to help reduce heparin product overdose errors caused by misinterpretation of the drug strength displayed in the labeling.

Cardiac Changes Linked With Specific ARVs in Perinatally Acquired HIV

Cardiac Changes Linked With Specific ARVs in Perinatally Acquired HIV

Individual antiretroviral medications have been linked with changes in cardiac structure in youths with perinatally acquired HIV.

Biologic Use Linked to Reduced Cardiovascular Risk in Inflammatory Arthritis

Biologic Use Linked to Reduced Cardiovascular Risk in Inflammatory Arthritis

Current biologic use was associated with a reduction in major cardiovascular events in patients with inflammatory arthritis.

Tiotropium Associated With Increased Cardiovascular Risk in COPD

Tiotropium Associated With Increased Cardiovascular Risk in COPD

Cardiovascular risk within 30 days of therapy start was approximately 2-fold higher with the incident use of tiotropium in COPD.

Cardiovascular Health Risks Identified With Diclofenac Use

Cardiovascular Health Risks Identified With Diclofenac Use

To investigate the cardiovascular risks associated with diclofenac, researchers conducted a series of cohort studies mimicking the design criteria of a clinical trial.

Age at Onset of Type 1 Diabetes Effects Mortality and Cardiovascular Complications

Age at Onset of Type 1 Diabetes Effects Mortality and Cardiovascular Complications

Investigators examine whether age of onset of type 1 diabetes affects mortality and cardiovascular risk.

IL-6 Receptor Polymorphisms May Be Associated With Aortic Aneurysm Risk

IL-6 Receptor Polymorphisms May Be Associated With Aortic Aneurysm Risk

Identification of interleukin 6 receptor single-nucleotide polymorphisms was associated with a significantly reduced risk for aortic aneurysm phenotypes.

Xenon Gas for Inhalation Therapy Gets Fast-Tracked for Post-Cardiac Arrest Syndrome

Xenon Gas for Inhalation Therapy Gets Fast-Tracked for Post-Cardiac Arrest Syndrome

Treatment with xenon may improve functional outcomes and reduce mortality in cardiac arrest survivors.

Optimal Dressing, Securement of Peripheral IV Catheters Not Yet Found

Optimal Dressing, Securement of Peripheral IV Catheters Not Yet Found

Tissue adhesive with polyurethane dressing, bordered polyurethane dressing, or using a securement device with polyurethane dressing were not superior to standard low-cost polyurethane dressing for peripheral intravenous catheters.

Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population

Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population

Investigators sought to compare cardiovascular risk and disease prevalence in the Hispanic and Latina population in the United States with and without a history of gestational diabetes.

Genetic Screening in Preventive Care: Advances and Challenges

Genetic Screening in Preventive Care: Advances and Challenges

Approximately 1% of individuals in the United States have a genetic predisposition to cancer or heart disease, and these individuals could be ideal candidates for genetic screening.

Cardiovascular Event Rates Vary by Kidney Failure Cause

Cardiovascular Event Rates Vary by Kidney Failure Cause

Among US dialysis patients, cardiovascular event rates are highest in those with diabetic nephropathy and lowest among those with IgA nephropathy.

AHA/ACC: Updated Management Guidelines for Adult Congenital Heart Disease

AHA/ACC: Updated Management Guidelines for Adult Congenital Heart Disease

The American College of Cardiology and American Heart Association developed updated guidelines on the evaluation, management, and monitoring of adults with congenital heart disease.

Casual Glucose Concentrations Predict Post-Surgical Myocardial Injury

Casual Glucose Concentrations Predict Post-Surgical Myocardial Injury

Glucose concentration assessment before noncardiac surgery may help clinicians predict the risk for postoperative myocardial injury in patients with and without diabetes.

Labeling for Several HIV Meds Updated to Include Interaction Data With DOACs

Labeling for Several HIV Meds Updated to Include Interaction Data With DOACs

If Tybost is given with atazanavir or darunavir, coadministration with rivaroxaban is not recommended due to a potentially increased bleeding risk.

Exercise Benefits for Myocardial Infarction Not Reduced by Traffic Pollutants

Exercise Benefits for Myocardial Infarction Not Reduced by Traffic Pollutants

All physical activities (sports, cycling, and gardening) except walking were associated with a significant decreased risk for myocardial infarction.

Which Opioids Are More Likely to Induce QT Interval Prolongation?

Which Opioids Are More Likely to Induce QT Interval Prolongation?

Studies comparing MMT to buprenorphine maintenance treatment (BMT) over 5-years found buprenorphine to be a safer drug for opioid maintenance treatment as it had no significant effect on QT prolongation.

Unapproved Opioid-Like Antidepressant Causes Adverse CV Events

Unapproved Opioid-Like Antidepressant Causes Adverse CV Events

While approved in Europe, Asia, and Latin America, tianeptine, an opioid receptor agonist, is an unscheduled pharmaceutical agent in the US that has been linked to serious adverse events, including death, when used for recreational purposes.

FDA Releases Guidance on Nicotine Replacement Therapy Product Development

FDA Releases Guidance on Nicotine Replacement Therapy Product Development

The FDA aims to support the development of novel inhaled nicotine replacement therapies to combat the public health crisis of tobacco use in the United States.

Silent Cardiac Impairment May Be Present in New-Onset, Drug-Naive Systemic Lupus Erythematosus

Silent Cardiac Impairment May Be Present in New-Onset, Drug-Naive Systemic Lupus Erythematosus

Data indicate that drug-naive new onset systemic lupus erythematosus was likely to involve silent cardiac impairment.

Independent Relationship Between CV Mortality, Oxidative DNA Damage in Type 2 Diabetes

Independent Relationship Between CV Mortality, Oxidative DNA Damage in Type 2 Diabetes

This represents the prospective study confirming an independent relationship between cardiovascular mortality and oxidative DNA damage in type 2 diabetes.

FDA: Cancer Treatment 'Alternative' May Cause Serious Heart Problems, Death

FDA: Cancer Treatment 'Alternative' May Cause Serious Heart Problems, Death

Cesium chloride is not approved by the FDA to treat cancer or any other disease.

Improving Sleep Quality May Reduce Cardiovascular Risk in Bipolar Disorder

Improving Sleep Quality May Reduce Cardiovascular Risk in Bipolar Disorder

The relationship between circadian rhythm and sleep measures and components of metabolic syndrome in patients with bipolar disorder.

CVD Risk Independently Predicted by Poor Lifestyle Factors

CVD Risk Independently Predicted by Poor Lifestyle Factors

High BMI, low physical activity levels, and frequent smoking and high genetic risk increased the risk for atrial fibrillation, coronary artery disease, hypertension, stroke, and diabetes.

Cardiovascular Disease Risk Lower in Women With Type 2 Diabetes

Cardiovascular Disease Risk Lower in Women With Type 2 Diabetes

Investigators examined gender differences in baseline characteristics and outcomes in patients with t2d and ASCVD.

USPSTF: Evidence Lacking for Adding Nontraditional Risk Factors to CVD

USPSTF: Evidence Lacking for Adding Nontraditional Risk Factors to CVD

Insufficient evidence for adding to traditional cardiovascular disease risk assessment in asymptomatic adults.

Blister Packs for Several Meds Recalled Due to Risk of Harm to Children

Blister Packs for Several Meds Recalled Due to Risk of Harm to Children

The recall affects approximately 470,000 units that include drugs packaged with 3 to 10 tablets per blister card. The blister packs were developed for use in hospitals, however some were sent to retail pharmacies and were likely dispensed for in-home use.

Increased Suicide Risk in Cardiovascular Disease With Highest Rates in Younger Patients

Increased Suicide Risk in Cardiovascular Disease With Highest Rates in Younger Patients

Patients with these cardiovascular diseases would benefit from early psychiatric help.

Atypical Antipsychotic Use and CV Events in Youth: What's the Link?

Atypical Antipsychotic Use and CV Events in Youth: What's the Link?

The retrospective cohort study involved a search of Medicaid claims of pediatric patients aged 5 to 20 years who were initiated on atypical antipsychotic medications.

Gastroprotective Effects of PPIs, H2RAs Compared in Patients on Clopidogrel

Gastroprotective Effects of PPIs, H2RAs Compared in Patients on Clopidogrel

For this study, researchers searched several large databases (from 1980 to 2016) for randomized, controlled trials (RCTs) that compared clinical outcomes in patients on DAPT taking PPIs or H2RAs.

Cardiovascular Events Independently Predicted by Erectile Dysfunction

Cardiovascular Events Independently Predicted by Erectile Dysfunction

Significantly more coronary heart and cardiovascular disease hard events occurred in individuals with erectile dysfunction vs those without.

NSAID Use Mediates CVD Risk in Osteoarthritis

NSAID Use Mediates CVD Risk in Osteoarthritis

Nonsteroidal anti-inflammatory drug use mediated a substantial amount of cardiovascular disease risk in osteoarthritis.

Many AKI Reports in FAERS Linked to Drugs Not Recognized as Nephrotoxic

Many AKI Reports in FAERS Linked to Drugs Not Recognized as Nephrotoxic

According to the authors, this is the first study to identify medications most commonly reported for a specific adverse reaction using this database.

USPSTF Does Not Recommend Electrocardiography Screening in Low-Risk CVD

USPSTF Does Not Recommend Electrocardiography Screening in Low-Risk CVD

The United States Preventive Services Task Force does not recommend screening with resting or exercise electrocardiography in asymptomatic individuals at low risk for cardiovascular disease events.

Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

An increased risk for cardiovascular disease with ritonavir-boosted darunavir regimens for HIV was identified in a prospective multicenter study.

Revised Equation May Improve Accuracy of Cardiovascular Disease Risk Estimates

Revised Equation May Improve Accuracy of Cardiovascular Disease Risk Estimates

Multiple studies have indicated that the 2013 PCEs - published by the American College of Cardiology/American Heart Association Task Force on Practice Guidelines - substantially misestimated CVD risk.

Perioperative Cardiovascular Events More Common in Diabetes

Perioperative Cardiovascular Events More Common in Diabetes

Perioperative major adverse cardiovascular and cerebrovascular events may be more common in patients with diabetes.

Celecoxib Associated With Lower MACE Risk Than Naproxen and Ibuprofen

Celecoxib Associated With Lower MACE Risk Than Naproxen and Ibuprofen

Patients taking celecoxib for arthritis who were at risk for cardiovascular events experienced better safety outcomes than with naproxen or ibuprofen.

AHA Reconfirms Oily Fish Consumption for Heart Health

AHA Reconfirms Oily Fish Consumption for Heart Health

The American Heart Association has reconfirmed their position on consuming fish rich in omega-3 fatty acids.

FDA Approves Epoetin Alfa Biosimilar Retacrit

FDA Approves Epoetin Alfa Biosimilar Retacrit

The approval of Retacrit was based on a review of evidence that included human pharmacokinetic/pharmacodynamic data and clinical immunogenicity data which demonstrated a high degree of similarity between Retacrit and its reference product.

AHA: Annual OB/GYN Appointment Can Benefit Women's Heart Health

AHA: Annual OB/GYN Appointment Can Benefit Women's Heart Health

An annual wellness exam performed by an OB/GYN can be used to evaluate a woman's heart health.

Biomarkers of Oxidative Stress Do Not Predict MACE in Type 2 Diabetes

Biomarkers of Oxidative Stress Do Not Predict MACE in Type 2 Diabetes

Investigators examined 6 biomarkers for predicting adverse cardiovascular outcomes in patients with type 2 diabetes.

Depression in Patients With Dementia May Increase Risk for Heart Disease

Depression in Patients With Dementia May Increase Risk for Heart Disease

Clinicians should take depression into careful consideration when treating patients with Alzheimer dementia, as the two conditions combined may predispose patients to cardiovascular disease more than either condition alone.

Liquid Nicotine Exposure in Children Declining, But Still a Threat

Liquid Nicotine Exposure in Children Declining, But Still a Threat

The rate of liquid nicotine exposure in children younger than 6 years of age has declined since 2015, but it continues to pose a serious poisoning risk.

Smoking Cessation Pharmacotherapies May Not Increase MACE

Smoking Cessation Pharmacotherapies May Not Increase MACE

There were no observable differences in the incidence of any cardiovascular events across the smoking cessation treatment groups.

FDA Announces New Initiative Aimed at Stopping Youth Use of E-Cigarettes

FDA Announces New Initiative Aimed at Stopping Youth Use of E-Cigarettes

In a wide ranging statement, the FDA commissioner Scott Gottlieb, MD, specifically targets novel nicotine-delivery products as being problematic since many of these devices resemble USB flash drives, have high nicotine levels and have emissions that are hard to see.

AHA: Assessment and Promotion of Physical Activity for CVD Prevention

AHA: Assessment and Promotion of Physical Activity for CVD Prevention

The American Heart Association provided updated guidelines for the routine assessment of physical activity for healthcare systems and providers as a way to prevent future health complications.

Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health

Psoriasis Treatment Ixekizumab Safe for Cardiovascular Health

Biologic therapies for psoriasis may have an impact on cardiovascular parameters, potentially resulting in the occurrence of major adverse cardiovascular events.

Menopause Symptom Severity May Predict Heart Disease

Menopause Symptom Severity May Predict Heart Disease

Researchers examined whether menopausal symptoms, quality of life, and depression are related to arterial stiffness, a risk factor for cardiovascular disease.

ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation

ACC and AHA Release 2018 Quality Measures for Cardiac Rehabilitation

New Class 1 recommendations involve the referral of inpatients and outpatients to cardiac rehabilitation programs that include exercise training.

Smoking Cessation Rates in Acute Coronary Syndrome With Varenicline

Smoking Cessation Rates in Acute Coronary Syndrome With Varenicline

Although varenicline was effective for short-term smoking cessation, more than half of the patients in the EVITA trial relapsed after 1 year.

Myopericarditis Risk in Adults Following Live Viral Vaccination Rare

Myopericarditis Risk in Adults Following Live Viral Vaccination Rare

Findings confirm that cardiovascular complications related to commonly-administered, live viral vaccination are rare in adults.

Electronic Cigarettes Do Not Appear to Promote Smoking Cessation

Electronic Cigarettes Do Not Appear to Promote Smoking Cessation

At 6 months, researchers found a negative association between electronic cigarette use and subsequent smoking cessation.

FDA Seeks Physician Opinions on Flavored Tobacco Products

FDA Seeks Physician Opinions on Flavored Tobacco Products

The FDA is seeking data, research, and general information regarding the role that flavors play in youth smoking.

Pioglitazone Lowers Cardiovascular, Noncardiovascular Mortality in Diabetes

Pioglitazone Lowers Cardiovascular, Noncardiovascular Mortality in Diabetes

For patients with type 2 diabetes, pioglitazone use may be associated with decreases in both cardiovascular and noncardiovascular mortality.

After Cardiovascular Event, Depression Symptoms Increase Mortality Risk

After Cardiovascular Event, Depression Symptoms Increase Mortality Risk

Positive emotions and low levels of depression after a CVD event are associated with low risk for mortality.

Long-Term Cardiovascular Benefits Associated With Sodium-Glucose Cotransporter 2 Inhibitors

Long-Term Cardiovascular Benefits Associated With Sodium-Glucose Cotransporter 2 Inhibitors

Use of sodium-glucose cotransporter inhibitors resulted in significant reductions in hemoglobin A1c, fasting blood glucose, and body weight.

CVD Risk Attenuated With Greater Cardiorespiratory Fitness

CVD Risk Attenuated With Greater Cardiorespiratory Fitness

Increasing coronary artery calcium correlated with increased CVD events, whereas increasing cardiorespiratory fitness tended to correlate with decreased CVD events.

Cardiovascular Risk Reduction in Rheumatoid Arthritis With Diabetes

Cardiovascular Risk Reduction in Rheumatoid Arthritis With Diabetes

Patients with rheumatoid arthritis and diabetes treated with abatacept may have a lower risk for myocardial infarction, stroke/transient ischemic attack, and coronary revascularization compared with tumor necrosis factor inhibitors.

Using Monetary Incentives to Encourage Smoking Cessation

Using Monetary Incentives to Encourage Smoking Cessation

Abstinence-contingent incentives improved smoking cessation outcomes among economically disadvantaged smokers with mental illness.

Smoke-Free Ordinances Lower Lung Cancer Risk

Smoke-Free Ordinances Lower Lung Cancer Risk

Smoke-free ordinances may reduce the number of lung cancer cases.

FDA Alert: Febuxostat May Increase Heart-Related Deaths

FDA Alert: Febuxostat May Increase Heart-Related Deaths

FDA released a safety alert that gout medication shows increased risk for heart-related death.

FDA Safety Alert: Biotin Interferes With Cardiac Troponin Results

FDA Safety Alert: Biotin Interferes With Cardiac Troponin Results

FDA releases safety alert that biotin can significantly interfere with certain lab tests and cause incorrect results which may go undetected.

Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis

Canakinumab May Lower Lung Cancer Incidence in Patients With Atherosclerosis

Anti-inflammatory therapy with canakinumab may result in a significantly lower incidence of lung cancer and lung cancer mortality.

High Nicotine Levels in E-Cigarettes May Increase Smoking Frequency

High Nicotine Levels in E-Cigarettes May Increase Smoking Frequency

Adolescents who use e-cigarettes with higher concentrations of nicotine may be at risk for progressively increasing the frequency and intensity of smoking and vaping.

Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

Factors Associated With Accelerated Atherosclerosis in Spondyloarthritis Without Overt CVD

Certain factors have been associated with accelerated atherosclerosis in spondyloarthritis without overt cardiovascular disease.

Cardiovascular Risk Examined in HIV-Positive Premenopausal Women

Cardiovascular Risk Examined in HIV-Positive Premenopausal Women

Traditional risk factors for cardiovascular disease are linked to a higher risk of heart disease in HIV-positive premenopausal women than HIV itself.

Management of Cardiovascular Risk Factors Still Key for People With RA

Management of Cardiovascular Risk Factors Still Key for People With RA

Knowledge regarding the impact of various risk factors for cardiovascular disease (CVD) events is essential for the establishment of individualized risk evaluation and prevention.

Liraglutide Receives FDA Approval For MACE Reduction in Type 2 Diabetes

Liraglutide Receives FDA Approval For MACE Reduction in Type 2 Diabetes

Liraglutide has received approval by the US Food and Drug Administration for a new indication to reduce the risk of MACE in type 2 diabetes patients.

Cardiovascular Disease Risk and Dietary Fat Intake: Update and Expert Roundtable

Cardiovascular Disease Risk and Dietary Fat Intake: Update and Expert Roundtable

The American Heart Association has shifted its dietary recommendations from replacing total fat with carbohydrates to replacing saturated and trans fats with unsaturated fat.

Coronary Heart Disease Risk Higher With Unhealthy Plant Food Diet

Coronary Heart Disease Risk Higher With Unhealthy Plant Food Diet

Coronary heart disease risk may be increased in individuals who consume diets consisting of less healthy plant foods.

USPSTF Updated Guidelines on Behavioral Counseling for CVD Prevention, Plus Expert Interview

USPSTF Updated Guidelines on Behavioral Counseling for CVD Prevention, Plus Expert Interview

An overview of new USPSTF recommendations for behavioral lifestyle counseling for the prevention of cardiovascular disease plus an expert interview.

Coronary Artery Disease-Related Death Increased With Opioid Use in COPD

Coronary Artery Disease-Related Death Increased With Opioid Use in COPD

Opioid use increases cardiac event risk in older adults with chronic obstructive pulmonary disease.

Chronic Inflammatory Disorders Increase Cardiometabolic and Mortality Risks

Chronic Inflammatory Disorders Increase Cardiometabolic and Mortality Risks

The degree of risk for cardiometabolic events and all-cause mortality increased with nonsteroidal anti-inflammatory drugs and corticosteroid drugs.

CV-Related Mortality Risk Increased With End-Stage Renal Disease and RA

CV-Related Mortality Risk Increased With End-Stage Renal Disease and RA

Patients with rheumatoid arthritis and end-stage renal disease have an increased risk for CV-related and all cause mortality.

Short Sleep Duration May Increase Risk for CVD Mortality

Short Sleep Duration May Increase Risk for CVD Mortality

Mortality risk is increased in association to short sleep duration in cardiovascular disease and stroke.

How Accurate Are Home Blood Pressure Monitor Readings?

How Accurate Are Home Blood Pressure Monitor Readings?

New reports found that 70% of home blood pressure monitor readings are inaccurate.

Anticoagulant Recall: Incorrect Dose Discovered in Bottle

Anticoagulant Recall: Incorrect Dose Discovered in Bottle

Bristol-Myers Squibb is recalling one lot of Eliquis after finding that 1 of the bottles contained the wrong dosage.

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Subclinical Myocardial Damage in Obesity May Be Mitigated by Physical Activity

Individuals who had the lowest levels of recommended physical activity had elevated levels of high-sensitivity cardiac troponin T.

Does Monthly, High-Dose Vitamin D Supplementation Prevent CVD?

Does Monthly, High-Dose Vitamin D Supplementation Prevent CVD?

A randomized double-blind placebo-controlled trial examined the relationship between high-dose oral vitamin D supplementation and reduced risk of cardiovascular disease.

Cardiovascular and Mortality Risk Reduction in Type 1 Diabetes

Cardiovascular and Mortality Risk Reduction in Type 1 Diabetes

There was a steep graded association between controlled cardiovascular risk factors and outcomes in patients with type 1 diabetes.

Cardiovascular Disease Risk Increases With Body Weight Fluctuations

Cardiovascular Disease Risk Increases With Body Weight Fluctuations

Increases in body weight fluctuations were associated with greater risk for coronary and cardiovascular events and death.

CVD, Mortality Risk in Older Women Predicted by Tooth Loss and Periodontitis

CVD, Mortality Risk in Older Women Predicted by Tooth Loss and Periodontitis

Periodontitis was associated with an increased mortality risk while edentulism was linked with an increased cardiovascular disease risk.

Sign Up for Free e-Newsletters